Corporate Presentation
Download
1 / 12

Corporate Presentation January 2009 - PowerPoint PPT Presentation


  • 105 Views
  • Uploaded on

Corporate Presentation January 2009. Ithaka Life Sciences Ltd. Advisory & management business started in 2000 Commercialising life science technologies: Business creation & business plans Technical, IP & commercial review & due diligence Sourcing investment finance

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Corporate Presentation January 2009' - kibo-lucas


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Ithaka life sciences ltd
Ithaka Life Sciences Ltd

  • Advisory & management business started in 2000

  • Commercialising life science technologies:

    • Business creation & business plans

    • Technical, IP & commercial review & due diligence

    • Sourcing investment finance

    • Project planning and management e.g. clinical trials

    • Interim management, coaching & mentoring

    • Facilitation service: commercial goals and planning

    • Strategic advice: development & implementation e.g. market mapping


Ithaka track record
Ithaka Track Record

  • >100 assignments completed for >60 clients

  • 8 university spin-outs created and financed

  • >£20 million funding for clients

    • Venture capital, corporate deals and grants

  • Commercial & IP reviews, & market research undertaken for >20 organisations

  • Due diligence conducted for 9 investment funds

  • Strong expertise in drug discovery & development

  • Unrivalled network of contacts

    • Strategic alliance with Ruston Poole International


Ithaka Board

Paul Rodgers

Axis Genetics, Pestax, AGC, Tate & Lyle

Gavin Scott Duncan

Hydron, ICI, Reckitt & Colman, Guinness etc.

Kim Heyworth

WHEB Ventures


Ithaka consultants
Ithaka Consultants

  • John AdairBiopharmaceutical R&D (Axis Genetics, Scotgen, Celltech, Searle)

  • Sue BuchananMarketing & business development (GeneMedix, PA Consulting, NHS etc.)

  • Richard CummingLife science product development & marketing (Amersham, GE Healthcare)

  • Malcolm RhodesLife science research commercialisation (Serologicals, Celltech, Pfizer etc.)

  • Bill PrimroseDrug discovery & development (PanTherix, SioKem etc.)

  • Mark TreherneDrug discovery & development (Xention, Pfizer etc.)

  • Paula WittelsMedical devices & diagnostics (Pfizer, Quintiles etc.)

  • Grahaem BrownClinical research (UCB Celltech, Pfizer, Novartis etc.)




Technologies and markets

Technologies

Cell therapy

Therapeutic proteins & peptides

Vaccines

Biomarkers

Natural products

Genomics & proteomics

Sensors

Diagnostics

Medical devices

Fermentation & bioprocessing

In silico molecular modelling

Markets

Drug discovery & development

Oncology, endocrine disorders, inflammatory, infectious & metabolic disease

Wound healing

Nutraceuticals & phytomedicines

In vitro diagnostics

Agrochemicals

Plant breeding

Fine chemicals

Technologies and Markets


Typical assignments
Typical Assignments

  • Business creation & sourcing finance

    • Psynova Neurotech & Smart Holograms

  • Technical, commercial and market evaluation

    • e2v biosensors: rapid protein analysis

    • Selective Antibodies: small molecule immunoassays

  • Due diligence

    • NVM (Gentronix), YFM (Plasticell) & NESTA (Cytox)

  • Strategic advice

    • OneNorth East, Smith & Nephew

  • Interim management, mentoring & coaching

    • e2v biosensors, deltaDOT, Theryte, CRB & Crossgen

  • Facilitation

    • Scottish Enterprise Proof of Concept Fund


Case study smart holograms
Case Study: Smart Holograms

  • Novel hologram sensor technology

    • Potential applications in medical, environment and industrial sectors

  • Ithaka role

    • Commercial strategy, IP audit, business plan and finance

    • Paul Rodgers: interim CEO then chairman

  • Results

    • University spin-out company 2002

    • Focus on healthcare diagnostics

    • £750k seed funding (including corporate deal)

    • £8M Series A funding in 2004/5 at £17M valuation

    • University Challenge Fund: 3-fold return on investment

    • Three blue chip corporate partners

    • First product launch in 2008

    • Current valuation £80M


Case study e2v biosensors
Case Study: e2v biosensors

  • Wholly owned subsidiary of e2v technologies plc (LSE - £200M turnover)

  • Novel immunoassay technology

    • Potential applications in medical, life science R&D, pharma R&D, biodefence and food sectors

  • Ithaka role

    • Independent market assessment & development of commercial strategy

    • Team of 5 consultants deployed

  • Results

    • Focus on point of care diagnostics – rapid, ultrasensitive test for Troponin recommended for first product

    • Paul Rodgers appointed as CEO

    • Business plan

    • £850k budget for current financial year secured


Why work with ithaka
Why Work with Ithaka?

  • Personal experience

    • Technology commercialisation

    • New ventures

    • Fund raising

    • Growth through strategic partnerships

    • Across the life science spectrum

  • Multi-disciplinary team approach

  • Unique network of contacts

  • Support tailored to meet the evolving needs of a growing business


ad